Clinical Trials Directory

Trials / Terminated

TerminatedNCT01512381

Atrioventricular Node Ablation in Patients With Atrial Fibrillation and Moderate Chronic Heart Failure

Variant of Stimulation in Atrioventricular Node Ablation (VISTA) in Patients With Atrial Fibrillation and Moderate Chronic Heart Failure

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether cardiac resynchronization therapy (CRT) is superior to interventricular right ventricle (RV) septal pacing in respect of reverse remodeling (LV ESD) and morbidity in patients with less preserved (less than 45%) ejection fraction (EF), persistent/permanent atrial fibrillation (AF) who successfully received atrioventricular (AV) junction ablation ablation (100% pacemaker dependency)

Conditions

Interventions

TypeNameDescription
DEVICEImplantation of CRT deviceRV lead of CRT system is implanted into the middle part of interventricular septum
DEVICEImplantation of conventional VVI(R) pacemakerRV lead is implanted into the middle part of interventricular septum

Timeline

Start date
2010-12-01
Primary completion
2017-09-01
Completion
2017-12-01
First posted
2012-01-19
Last updated
2018-06-06

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT01512381. Inclusion in this directory is not an endorsement.